Mechanism and Research Interest

Primary Biological Pathway: The KPV “Inflammation Brake” The distinguishing feature of the Klow blend is the addition of KPV (Lysine-Proline-Valine). This C-terminal tripeptide of α-MSH (Alpha-Melanocyte Stimulating Hormone) exhibits profound anti-inflammatory properties without the pigmentary effects of the full hormone. Research utilising this pen investigates KPV’s ability to enter the nucleus and inhibit NF-κB activation, effectively dampening the “cytokine storm” that often arrests the healing process in chronic wounds. In this 80mg blend, KPV acts as the permissive gatekeeper, reducing the inflammatory noise so that the regenerative signals of GHK-Cu, BPC-157, and TB-500 can function optimally.